News

MultiplAI: The company focused on screening for cardiovascular and other complex diseases

Published on: 02/08/2023

MultiplAI: The company focused on screening for cardiovascular and other complex diseases
Member News

Learn more about the newest member to join our global community: MultiplAI. It is a company based in London focused on developing precision medicine technology.

MultiplAI Health is a London-based techbio company with the vision to provide universal access to genomic screening for cardiovascular and other complex diseases. Our current focus is developing a groundbreaking AI-driven RNA-based blood test to revolutionise screening for cardiovascular disease (CVD), the leading cause of global mortality, claiming 18 million lives annually. MultiplAI has a laboratory-validated product, is conducting clinical studies to generate proprietary data and is aiming for US commercial market entry by 2024. MultiplAI is based in the UK with additional operations in the USA, Spain and Argentina.

As a TechBio company focused on developing precision medicine technology to revolutionise screening for complex diseases, we are focused on providing solutions to several areas in the healthcare space including private and public primary care, government healthcare systems and pharma.

As a young health technology company, a core focuses for MultiplAI is on developing partnerships to further our research efforts and build relationships that will assist us in further funding opportunities.

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *